GlassScriptPhysician profile
Steven Song
NPI 1811665854
$1,616.99
in general payments reported to CMS, 2019-2025
20 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $335 · 2022: $124 · 2023: $310 · 2024: $612 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $314.20 | 2021-2025 | |
| Phathom Pharmaceuticals, INC. | $213.88 | 2024 | Voquezna |
| Janssen Pharmaceuticals, INC | $196.59 | 2021-2024 | Xarelto |
| Lilly USA, LLC | $185.29 | 2021-2024 | Mounjaro, Zepbound |
| Abbvie INC. | $174.83 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.20 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $66.18 | 2024-2025 | Airsupra, Farxiga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.60 | 2023-2024 | Xifaxan |
| Dexcom, INC. | $43.17 | 2023 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $41.00 | 2022 | |
| Sunovion Pharmaceuticals INC. | $38.35 | 2021 | |
| Ironwood Pharmaceuticals, INC | $31.20 | 2021 | |
| Exact Sciences Corporation | $28.49 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $25.54 | 2024 | |
| Xeris Pharmaceuticals, INC. | $23.49 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.43 | 2024 | Lifevest |
| Lundbeck LLC | $19.48 | 2024 | Rexulti |
| Glaxosmithkline, LLC. | $17.75 | 2024 | Arexvy, Shingrix |
| Scilex Pharmaceuticals INC. | $17.27 | 2024 | |
| Amgen INC. | $16.05 | 2023 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Song listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.